Eton Pharmaceuticals (ETON) Change in Account Payables (2018 - 2025)

Eton Pharmaceuticals has disclosed Change in Account Payables across 8 years of filings, most recently posting -$3.3 million for Q4 2025.

• In Q4 2025, Change in Account Payables fell 321.59% year-over-year to -$3.3 million; the TTM figure through Dec 2025 stood at $6.8 million (up 193.7% YoY), while the FY2025 annual figure was $6.8 million, up 193.7% from the prior year.
• Change in Account Payables came in at -$3.3 million for Q4 2025 at Eton Pharmaceuticals, down from $2.1 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $7.3 million in Q2 2025 to a low of -$3.3 million in Q4 2025.
• Average Change in Account Payables over 5 years is $430050.0, with a median of $11500.0 recorded in 2022.
• Year-over-year, Change in Account Payables sank 1033.09% in 2021 and soared 5688.46% in 2025.
• Over 5 years, Change in Account Payables stood at -$1.3 million in 2021, then surged by 156.11% to $712000.0 in 2022, then plunged by 85.25% to $105000.0 in 2023, then jumped by 1311.43% to $1.5 million in 2024, then tumbled by 321.59% to -$3.3 million in 2025.
• Per Business Quant data, the three most recent Change in Account Payables figures were -$3.3 million in Q4 2025, $2.1 million in Q3 2025, and $7.3 million in Q2 2025.